Prostate cancer: key references and evidence
References
Black R, Stockton D (eds). Cancer scenarios: An aid to planning cancer services in Scotland in the next decade. Edinburgh: Scottish Executive, 2001.
Brewster DH, Fraser LA, Harris V, Black RJ. Rising incidence of prostate cancer in Scotland: increased risk or increased detection? BJU Int 2000; 85: 463-472.
Brewster DH, Stockton DL, Harvey J, Mackay M. Reliability of cancer registration data in Scotland, 1997. Eur J Cancer 2002; 38: 414-417.
Brown, K.F. et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. British Journal of Cancer 118, 1-12 (2018).
Burford D, Kirkby M, Austoker J. Prostate Cancer risk Management Programme - PSA testing in asymptomatic men (265Kb) NHS Cancer Screening Programmes, 2009.
Ferlay J, Bray F, Pisani P, Parkin DM.Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. version 2.0. Lyon: IARCPress, 2004. Lyon: IARCPress, 2004. (The Global Cancer Observatory website is an electronic version of this).
Forman D, Stockton D, Moller H, Quinn M, Babb P, De Angelis R, Micheli A. Cancer Prevalence in the UK: results from the EUROPREVAL Study. Annals of Oncol 2003; 14: 648-654.
Howard GCW, Thomson CS, Stroner PL, Goodman CM, Windsor PM, Brewster DH. Patterns of referral, management and survival of patients diagnosed with prostate cancer in Scotland during 1988 and 1993: results of a national, retrospective population-based audit. BJU Int 2001; 87: 339-347.
Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD004720. DOI: 10.1002/14651858.CD004720.pub3.
Laing, K, Bramwell, S, McNeill, A, Corr, B, Lam, T. Prostate cancer is Scotland: does geography matter? An analysis of incidence, disease characteristics and survival between urban and rural areas. J Clin Urol. 2014;7(3):176–84.
Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman M, Hakulinen T, Gatta G, Berrino F, Capocaccia R & the EUROPREVAL Working Group. Cancer prevalence in European registry areas. Annals of Oncology 2002; 13: 840865.
Perez-Cornago A , Key TJ , Allen NE , et al . Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study. Br J Cancer 2017;117:1562–71.
Scottish Executive Health Department. Cancer in Scotland: Action for Change, 2001. Edinburgh: Scottish Executive, 2001.
Sharpe K. Better Cancer Care: Better Cancer Care: An Aid to Planning Cancer Services. Cancer Incidence Projections for Scotland (2006 - 2020) Updated to reflect 2006-based Population Projections. Edinburgh: Scottish Government, 2008.
Scottish Government Health and Social Care Directorate. Beating Cancer: Ambition and Action. Edinburgh: Scottish Government, 2016.
Scottish Executive Health Department. Cancer in Scotland: Sustaining Change, 2004. Edinburgh: Scottish Executive, 2004.
Scottish Government Health Directorate. Better Cancer Care, An Action Plan, 2008 Edinburgh: Scottish Government, 2008.
Scottish Government Health Directorate. Prostate Cancer Risk Management Programme - PSA testing information Edinburgh: Scottish Government, 2013.
Stockton DL. Sustaining change: Cancer Incidence Projections for Scotland (2001 - 2020) - An Aid to Planning Cancer Services. Edinburgh: Scottish Executive, 2004.
Wood H, Cooper N, Rowan S, Quinn M. Prostate. (433Kb) In: Quinn M, Wood H, Cooper N, Rowan S (eds). Cancer Atlas of the United Kingdom and Ireland 1991-2000. ONS SMPS No. 68. Basingstoke: Palgrave MacMillan, 2005.
Effectiveness evidence
ScotPHO's purpose is to describe the pattern of health across the Scottish population. As a supplementary service to users, we include the following links to external sources of quality-assured evidence on effectiveness of interventions which may include relevant material for this topic. These links are provided as an aid to users. They are by no means exhaustive nor should they be necessarily viewed as authoritative.
NHS Health Scotland: Scottish briefings on NICE public health guidance
Centre for Reviews and Dissemination
Cochrane Library: Browse by topic
National Institute for Health and Care Excellence (NICE) Evidence services: Evidence search
National Institute for Health and Care Excellence (NICE) Guidance: Find guidance
Scottish Intercollegiate Guidelines Network (SIGN)
Please note: ScotPHO is not responsible for the content or reliability of linked websites and does not necessarily endorse the views expressed within them. Listing should not be taken as endorsement of any kind. ScotPHO can take no responsibility for information contained on websites maintained by other organisations or for actions taken as a result of information contained on websites maintained by other organisations.
To report a broken link on the ScotPHO website, please email details to the ScotPHO team of the web page containing the broken link together with the web address you were unable to access.
